Rapid onset of muscle weakness (Rhabdomyolysis) associated with the combined use of simvastatin and colchicine

被引:55
作者
Justiniano, Maria [1 ]
Dold, Sylvia [1 ]
Espinoza, Luis R. [1 ]
机构
[1] LSU, Hlth Sci Ctr, Dept Internal Med, Rheumatol Sect, New Orleans, LA USA
关键词
myopathy; rhabdomyolysis; statins; colchicine;
D O I
10.1097/RHU.0b013e318156d977
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis. Profound muscle weakness of lower extremities with inability to stand up and/or walk was present. Elevated muscle enzymes and findings on electromyography were consistent with myopathy. Rapid improvement in muscle strength accompanied by prompt resolution of abnormal elevation of muscle enzymes followed cessation of both medications. Both colchicine and statin therapy may be associated with myopathy, which usually occurs after several months of therapy. The concomitant use, however, of colchicine and statin has been associated with the rapid onset of muscle weakness. Four patients with similar clinical and laboratory characteristics to our patient's after the combined use of colchicine and statins have been described in the literature. Patients receiving combination therapy with colchicine and simvastatin, particularly in the presence of renal insufficiency, should be monitored for the development of myopathy, including rhabdomyolysis.
引用
收藏
页码:266 / 268
页数:3
相关论文
共 15 条
[1]
Acute myopathy in a patient with concomitant use of pravastatin and colchicine [J].
Alayli, G ;
Cengiz, K ;
Cantürk, F ;
Durmus, D ;
Akyol, Y ;
Menekse, EB .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) :1358-1361
[2]
Clinical perspectives of statin-induced rhabdomyolysis [J].
Antons, KA ;
Williams, CD ;
Baker, SK ;
Phillips, PS .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05) :400-409
[3]
Possible colchicine rhabdomyolysis in a fluvastatin-treated patient [J].
Atasoyu, EM ;
Evrenkaya, TR ;
Solmazgul, E .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) :1368-1369
[4]
Cytoskeletal myotoxicity from simvastatin and colchicine [J].
Baker, SK ;
Goodwin, S ;
Sur, M ;
Tarnopolsky, MA .
MUSCLE & NERVE, 2004, 30 (06) :799-802
[5]
Davidson MH, 2000, NUTR METAB CARDIOVAS, V10, P253
[6]
GRUER PJ, 1999, AM J CARDIOL, V84, P1042
[7]
Outcomes in 45 patients with statin-associated myopathy [J].
Hansen, KE ;
Hildebrand, JP ;
Ferguson, EE ;
Stein, JH .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (22) :2671-2676
[8]
Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin [J].
Hsu, WC ;
Chen, WH ;
Chang, MT ;
Chiu, HC .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (05) :266-268
[9]
Statin safety: A systematic review [J].
Law, M ;
Rudnicka, AR .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A) :52C-60C
[10]
FDA adverse event reports on statin-associated rhabdomyolysis [J].
Omar, MA ;
Wilson, JP .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) :288-295